文献速递免疫规划卫生政策与健康促进

评估次国家疫苗接种覆盖率的抽样方法比较:中非共和国与刚果民主共和国的试点研究

Comparing sampling approaches for assessing sub-national vaccination coverage: a pilot study in Central African Republic and the Democratic Republic of Congo.
PubMed 文献 · Vaccine · 2026-02-18

该研究在五个卫生区同步应用三种替代抽样方法(KSPH-VCS、GIS抽样、LQAS)与WHO疫苗接种覆盖率整群调查(WHO-VCCS)进行比较,评估12-23月龄儿童17项疫苗接种指标的效度和精确度。结果显示GIS与WHO-VCCS一致性最高但置信区间最宽,KSPH-VCS置信区间较窄且效度中等,LQAS估计值超出WHO置信区间比例最高;在地区/国家层面汇总时各方法表现相似。

要点

  • GIS抽样与WHO-VCCS一致性最高,但置信区间宽度比中位数为2.2。
  • KSPH-VCS置信区间较窄(宽度比1.7),效度中等(22.4%估计值在5个百分点内)。
  • LQAS估计值超出WHO置信区间的比例最高(中位数18.5个百分点)。

核心结论

  • KSPH-VCS和GIS抽样可作为WHO-VCCS的可行替代方案,尤其适用于产生可接受精度的汇总估计。

研究设计与样本

  • 横断面研究,在中非共和国和刚果民主共和国的五个城市和农村卫生区同步应用四种抽样方法,针对12-23月龄儿童,每个卫生区评估17项疫苗接种指标。

主要发现

  • GIS一致性最高(49.3%估计值在5个百分点内;41.2%在WHO置信区间内),但置信区间最宽(中位宽度比2.2)。
  • KSPH-VCS置信区间较窄(宽度比1.7),效度中等(22.4%在5个百分点内)。
  • LQAS估计值超出WHO置信区间的比例最高(中位数18.5个百分点)。
  • KSPH-VCS和GIS在5个卫生区中的3个与WHO-VCCS统计可比,LQAS在4个卫生区可比。
  • 汇总层面,所有替代抽样方法表现相似。

关键数值与推荐

  • 比较指标包括:与WHO-VCCS估计值的绝对差异(百分点)、是否包含在WHO 95%置信区间内、置信区间宽度比、超出WHO置信区间的估计比例。

临床怎么用

  • 在资源有限或行政数据不可靠的地区,可考虑使用KSPH-VCS或GIS抽样替代WHO-VCCS进行卫生区级疫苗接种覆盖率评估,尤其关注汇总估计时。

局限性

  • 需进一步研究评估成本、可行性及在不同环境下的适应性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccination coverage surveys (VCS) are essential for monitoring program performance, especially where administrative data are unreliable. While national and sub-national estimates are common, district-level data remain limited despite their value for local planning and equity monitoring. This study compared three alternative sampling approaches (ASAs)-Kinshasa School of Public Health VCS (KSPH-VCS), Geographic Information System (GIS)-based sampling, and Lot Quality Assurance Sampling (LQAS)-to the WHO Vaccination Coverage Cluster Survey (WHO-VCCS) in terms of validity and precision among children aged 12-23 months at the health district (HD) level. A cross-sectional study was conducted in five HDs (urban and rural) in the Central African Republic (CAR) and the Democratic Republic of Congo (DRC). All four approaches were applied simultaneously. For 17 vaccination indicators per HD, comparability to WHO-VCCS was assessed using four metrics: (i) absolute difference in percentage points (pp) between each ASA and the WHO-VCCS estimates, (ii) inclusion within WHO's 95% confidence intervals (CIs), (iii) CI width ratio, and (iv) proportion of estimates outside WHO CIs. Survey-adjusted logistic regressions, design effects (DEFF), and intra-cluster correlation coefficients (ICC) were analyzed. Aggregated results at regional/national levels were also simulated. GIS showed the highest concordance (49.3% of estimates within 5 pp.; 41.2% within WHO CIs) but had the widest CIs (median width ratio relative to WHO-VCCS: 2.2). KSPH-VCS had narrower CIs (1.7) and moderate validity (22.4% within 5 pp), while LQAS had the highest proportion of estimates outside WHO CIs (median: 18.5 pp). KSPH-VCS and GIS were statistically comparable to WHO-VCCS in 3 of 5 HDs; LQAS in 4. At aggregated levels, all ASAs performed similarly. KSPH-VCS and GIS offer viable options to WHO-VCCS, especially for producing aggregated estimates with acceptable precision. Further studies should assess cost, feasibility, and adaptability across settings.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kasonga JN, Hoff NA, Merritt S, et al. Comparing sampling approaches for assessing sub-national vaccination coverage: a pilot study in Central African Republic and the Democratic Republic of Congo. Vaccine. 2026. PMID: 41713235. doi:10.1016/j.vaccine.2026.128313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。